ClearPoint Neuro (CLPT) Research & Development (2011 - 2026)

ClearPoint Neuro (CLPT) has 15 years of Research & Development data on file, last reported at $6.7 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development rose 75.14% year-over-year to $6.7 million; the trailing twelve-month figure through Mar 2026 stood at $20.2 million (up 28.66% YoY), and the FY2025 full-year result was $16.5 million, up 13.7% from the prior year.
• Research & Development improved to $6.7 million in Q1 2026, from $5.8 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $6.7 million in Q1 2026 to a low of $2.4 million in Q2 2022.
• A 5-year average of $3.7 million and a median of $3.3 million in 2024 frame the typical range for Research & Development.
• Peak annual rise in Research & Development reached 85.6% in 2022, while the deepest fall reached 40.0% in 2022.
• Tracing CLPT's Research & Development over 5 years: stood at $2.5 million in 2022, then soared by 32.19% to $3.3 million in 2023, then soared by 61.88% to $5.4 million in 2024, then increased by 7.07% to $5.8 million in 2025, then advanced by 15.76% to $6.7 million in 2026.
• Business Quant data shows CLPT's Research & Development at $6.7 million in Q1 2026, $5.8 million in Q4 2025, and $3.8 million in Q3 2025.